Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-03-01 @ 10:08 AM
Study NCT ID:
NCT05431569
Status:
UNKNOWN
Last Update Posted:
2022-06-24
First Post:
2022-06-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
Sponsor:
Mabwell (Shanghai) Bioscience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-20
First Submit QC Date:
None
Study First Post Date:
2022-06-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-20
Last Update Post Date:
2022-06-24
Last Update Post Date Type:
ACTUAL